Rchr
J-GLOBAL ID:202001007874113787   Update date: Nov. 12, 2024

Taiji Hasegawa

Taiji Hasegawa
Research field  (1): Ophthalmology
Research theme for competitive and other funds  (1):
  • 2020 - 2023 視細胞による脈絡膜形態および血流変化の誘導メカニズムの解明
Papers (49):
  • Ryo Mukai, Keiko Kataoka, Koji Tanaka, Yasunori Miyara, Ichiro Maruko, Makiko Nakayama, Yuto Watanabe, Akiko Yamamoto, Yu Wakatsuki, Hajime Onoe, et al. One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in Japan. Scientific Reports. 2024. 14. 1
  • 片岡 恵子, 向井 亮, 湧川 空子, 田中 公二, 丸子 一朗, 中山 真紀子, 山本 亜希子, 板垣 可奈子, 小笠原 雅, 本庄 純一郎, et al. afliberceptからfaricimabへの切り替えによる短期的効果. 眼科臨床紀要. 2023. 16. 10. 725-726
  • Keiko Kataoka, Kanako Itagaki, Nozumu Hashiya, Sorako Wakugawa, Koji Tanaka, Makiko Nakayama, Akiko Yamamoto, Ryo Mukai, Jyunichiro Honjyo, Ichiro Maruko, et al. Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology. 2023. 262. 1. 43-51
  • Ryo Mukai, Keiko Kataoka, Koji Tanaka, Yasunori Miyara, Ichiro Maruko, Makiko Nakayama, Yuto Watanabe, Akiko Yamamoto, Yu Wakatsuki, Hajime Onoe, et al. Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan. Scientific reports. 2023. 13. 1. 8747-8747
  • 向井 亮, 片岡 恵子, 田中 公二, 宮良 安宣, 丸子 一朗, 中山 真紀子, 渡邊 裕斗, 山本 亜希子, 若月 優, 小野江 元, et al. 治療歴のない滲出型加齢黄斑変性に対するファリシマブ硝子体内投与の短期成績. 日本眼科学会雑誌. 2023. 127. 臨増. 182-182
more...
MISC (73):
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page